NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity. The goal of this program is to improve the management of intrahepatic and perihilar cholangiocarcinoma, the use of precision medicine for colorectal cancer (CRC), and cancer treatment in the era of COVID-19. After hearing and assimilating this program, the clinician will be better able to: 1. Manage intrahepatic and hilar cholangiocarcinoma with surgery, adjuvant therapy, and transplantation. 2. Select appropriate interventions for various subtypes of CRC. 3. Identify patients with CRC responding to immune checkpoint inhibitors. 4. Identify the predictors of COVID-19 death rates. 5. Adopt safety protocols for providing cancer treatment in the era of COVID-19.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2024-03-12 05:00:00
- End Date: 2024-03-12 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology